Analysis Of Income And Expense [Abstract]

Redcare Pharmacy N.V. - Filing #2154233

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-30	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-30
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	1,7 9 8,7 58 EUR	—	—	—	—	—	—	—	—	—	—	1,2 04, 35 2 EUR	—	—	—	—	—
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	226,000 EUR	—	—	—	—	—	—	—	—	—	—	339,000 EUR	—	—	—	—	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income from continuing operations	—	12,633,000 EUR	—	—	—	—	—	—	—	—	—	—	77 ,6 46 EUR	—	—	—	—	—
Comprehensive income	0 EUR	12,633,000 EUR	0 EUR	69,000 EUR	13 ,4 3 0 EUR	0 EUR	0 EUR	865,000 EUR	12 ,5 6 5 EUR	0 EUR	0 EUR	0 EUR	77 ,6 46 EUR	0 EUR	7 7,6 4 6 EUR	0 EUR	0 EUR	7 7,6 4 6 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	1 2 , 5 6 4 EUR	—	—	—	—	—	—	—	—	—	—	7 7, 6 4 6 EUR	—	—	—	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	—	69,000 EUR	—	—	—	—	—	—	—	—	—	—	0 EUR	—	—	—	—	—